_version_ 1783308289809842176
author Krakowsky, Rosanna H. E.
Wurm, Alexander A.
Gerloff, Dennis
Katzerke, Christiane
Bräuer-Hartmann, Daniela
Hartmann, Jens-Uwe
Wilke, Franziska
Thiede, Christian
Müller-Tidow, Carsten
Niederwieser, Dietger
Behre, Gerhard
author_facet Krakowsky, Rosanna H. E.
Wurm, Alexander A.
Gerloff, Dennis
Katzerke, Christiane
Bräuer-Hartmann, Daniela
Hartmann, Jens-Uwe
Wilke, Franziska
Thiede, Christian
Müller-Tidow, Carsten
Niederwieser, Dietger
Behre, Gerhard
author_sort Krakowsky, Rosanna H. E.
collection PubMed
description
format Online
Article
Text
id pubmed-5862828
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58628282018-03-22 miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia Krakowsky, Rosanna H. E. Wurm, Alexander A. Gerloff, Dennis Katzerke, Christiane Bräuer-Hartmann, Daniela Hartmann, Jens-Uwe Wilke, Franziska Thiede, Christian Müller-Tidow, Carsten Niederwieser, Dietger Behre, Gerhard Blood Cancer J Correspondence Nature Publishing Group UK 2018-03-21 /pmc/articles/PMC5862828/ /pubmed/29563490 http://dx.doi.org/10.1038/s41408-018-0070-y Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Krakowsky, Rosanna H. E.
Wurm, Alexander A.
Gerloff, Dennis
Katzerke, Christiane
Bräuer-Hartmann, Daniela
Hartmann, Jens-Uwe
Wilke, Franziska
Thiede, Christian
Müller-Tidow, Carsten
Niederwieser, Dietger
Behre, Gerhard
miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
title miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
title_full miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
title_fullStr miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
title_full_unstemmed miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
title_short miR-451a abrogates treatment resistance in FLT3-ITD-positive acute myeloid leukemia
title_sort mir-451a abrogates treatment resistance in flt3-itd-positive acute myeloid leukemia
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862828/
https://www.ncbi.nlm.nih.gov/pubmed/29563490
http://dx.doi.org/10.1038/s41408-018-0070-y
work_keys_str_mv AT krakowskyrosannahe mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT wurmalexandera mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT gerloffdennis mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT katzerkechristiane mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT brauerhartmanndaniela mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT hartmannjensuwe mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT wilkefranziska mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT thiedechristian mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT mullertidowcarsten mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT niederwieserdietger mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia
AT behregerhard mir451aabrogatestreatmentresistanceinflt3itdpositiveacutemyeloidleukemia